Tapentadol
Current strategies to mitigate the opioid crisis and manage chronic pain focus on new products that treat pain effectively with lower potential for abuse and addiction. |
These medications may be counterfeit and potentially unsafe. |
Tapentadol is a centrally-acting synthetic analgesic that is 18 times less potent than morphine in binding mu-opioid receptors. |
Controlled Substance. |
It is used to treat moderate to severe pain. Expand to see all locations within your area. |
Our results indicate that tapentadol ER is rarely sold illicitly in the United States. |
Management of pain or neuropathic pain associated with diabetic peripheral neuropathy DPN severe enough to require daily, around-the-clock, long-term analgesia for which alternative treatment options are inadequate. Not for use as an as-needed prn analgesic. |
Our results indicate that tapentadol ER is rarely sold illicitly in the United States. Tapentadol is approved in the United States, Canada, and other countries for the relief of moderate to severe chronic pain. |
The starting dose of Nucynta ER for all patients is 50 mg twice daily. |
Drug Uses Tapentadol is used to help relieve moderate to severe short-term pain such as pain from an injury or after surgery. |
